59.98 USD
↘ 6.57 (9.87%)AT CLOSE (11:59 AM EDT)
GRAIL, Inc. Common Stock
GRALNASDAQ • USD
60.57
↗ 0.59 (0.98%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
60.57
↗ 0.59 (0.98%)
Market: CLOSED
Open?$63.99
High?$65.53
Low?$59.66
Prev. Close?$66.55
Volume?760.5K
Avg. Volume?775.7K
VWAP?$60.86
Rel. Volume?0.98x
Bid / Ask
Bid?$59.13 × 100
Ask?$62.00 × 300
Spread?$2.87
Midpoint?$60.57
Valuation & Ratios
Market Cap?2.6B
Shares Out?42.9M
Float?34.8M
Float %?89.3%
P/E Ratio?N/A
P/B Ratio?1.03
EPS?-$9.21
Dividend?0.00%
Ex-Dividend?N/A
GRAIL, Inc. Common Stock (GRAL) trades at $59.98 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place GRAL at a fair price relative to peers.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Address
1525 O'BRIEN DRIVE
MENLO PARK, CA 94025
Phone: (833) 694-2553
MENLO PARK, CA 94025
Phone: (833) 694-2553
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?97
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.48Distress
Confidence?49%Low
Short InterestSqueeze Risk
Short % of Float?20.53%Squeeze Risk
Short Interest?7.2M
Days to Cover?11.4
Free Float34.8M
Avg Daily Volume626.4K
Settlement Date2026-05-15
Financial Health
Current Ratio?11.74Strong
Quick Ratio?11.51Strong
Cash Ratio?0.93Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.03CHEAP▾
Peers100
S&P97
P/S?16.49HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-7.0CHEAP▾
S&P97
EV/Sales?16.04HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-15.8%WEAK▾
S&P8
ROA?-14.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-292334000
Enterprise Value?$2.5B
Fundamentals ratios updated end of day